Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $481.60 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $214.66 | 15 | $0 (2023) |
| Medtronic, Inc. | $53.01 | 2 | $0 (2023) |
| Vertical Pharmaceuticals, LLC | $38.23 | 2 | $0 (2018) |
| DePuy Synthes Sales Inc. | $35.80 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $29.77 | 2 | $0 (2023) |
| Shire North American Group Inc | $25.89 | 2 | $0 (2019) |
| Orexigen Therapeutics, Inc. | $15.44 | 1 | $0 (2017) |
| Scilex Pharmaceuticals Inc. | $14.69 | 1 | $0 (2019) |
| Kaleo, Inc. | $14.08 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $14.06 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $84.39 | 4 | Medtronic, Inc. ($53.01) |
| 2022 | $12.27 | 1 | Mannkind Corporation ($12.27) |
| 2021 | $39.43 | 3 | Lilly USA, LLC ($39.43) |
| 2020 | $53.97 | 4 | Lilly USA, LLC ($39.91) |
| 2019 | $68.90 | 5 | Lilly USA, LLC ($42.93) |
| 2018 | $41.48 | 3 | Vertical Pharmaceuticals, LLC ($14.06) |
| 2017 | $181.16 | 10 | Lilly USA, LLC ($64.91) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Durable Pump | ||||||
| 05/01/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/08/2023 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 02/06/2023 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 03/07/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/06/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 06/04/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 03/01/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Diabetes | ||||||
| 12/07/2020 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Diabetes | ||||||
| 11/03/2020 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Diabetes | ||||||
| 02/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 07/01/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/04/2019 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 05/06/2019 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 04/15/2019 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Analgesic | ||||||
| 02/05/2019 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 12/03/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Endocrinology | ||||||
| 11/12/2018 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 05/21/2018 | Vertical Pharmaceuticals, LLC | DIVIGEL (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: HORMONE REPLACEMENT THERAPY | ||||||
| 12/04/2017 | Lilly USA, LLC | HUMULIN (Drug), HUMALOG, TRULICITY | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 11/28/2017 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Diabetes | ||||||
| 09/27/2017 | Lilly USA, LLC | HUMULIN (Drug), HUMALOG, TRULICITY | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Diabetes | ||||||
| 08/21/2017 | Vertical Pharmaceuticals, LLC | DIVIGEL (Drug), CORVITE FE W QUATREFOLIC | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: HORMONE REPLACEMENT THERAPY | ||||||
| 07/03/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: OBESITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 513 | 1,045 | $109,806 | $54,469 |
| 2022 | 7 | 531 | 1,025 | $87,338 | $54,889 |
| 2021 | 8 | 566 | 1,150 | $90,111 | $62,179 |
| 2020 | 8 | 496 | 978 | $68,124 | $46,638 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 157 | 433 | $28,387 | $16,746 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 170 | $30,142 | $12,576 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $23,964 | $8,400 | 35.1% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 35 | 90 | $9,635 | $6,793 | 70.5% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 67 | 186 | $11,074 | $5,399 | 48.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 11 | 33 | $3,096 | $2,123 | 68.6% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 19 | 24 | $2,146 | $1,437 | 67.0% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 15 | $1,363 | $995.55 | 73.1% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 169 | 424 | $24,593 | $16,729 | 68.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 183 | $25,116 | $14,194 | 56.5% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 42 | 101 | $11,091 | $7,805 | 70.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 79 | 79 | $13,006 | $7,346 | 56.5% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 73 | 187 | $8,559 | $5,408 | 63.2% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 13 | 34 | $3,410 | $2,349 | 68.9% |
| 99342 | New patient home visit, typically 30 minutes | Office | 2022 | 17 | 17 | $1,563 | $1,058 | 67.7% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 178 | 486 | $27,845 | $19,565 | 70.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 139 | 195 | $22,823 | $15,690 | 68.7% |
| 11056 | Removal of 2 to 4 thickened skin growths | Office | 2021 | 45 | 118 | $12,435 | $8,896 | 71.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 93 | 93 | $13,430 | $8,729 | 65.0% |
| 11720 | Removal of tissue from 1 to 5 finger or toe nails | Office | 2021 | 75 | 199 | $8,701 | $5,955 | 68.4% |
| 11055 | Removal of single thickened skin growth | Office | 2021 | 11 | 31 | $2,978 | $2,012 | 67.6% |
| 99347 | Established patient home visit, typically 15 minutes | Office | 2021 | 14 | 17 | $1,123 | $768.32 | 68.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 11 | $775.72 | $564.19 | 72.7% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2020 | 177 | 441 | $25,672 | $17,560 | 68.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 77 | 119 | $11,365 | $7,626 | 67.1% |
About Dr. Robert Briganti, D.P.M
Dr. Robert Briganti, D.P.M is a Podiatrist healthcare provider based in Lyndhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740303023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Briganti, D.P.M has received a total of $481.60 in payments from pharmaceutical and medical device companies, with $84.39 received in 2023. These payments were reported across 30 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($481.60).
As a Medicare-enrolled provider, Briganti has provided services to 2,106 Medicare beneficiaries, totaling 4,198 services with total Medicare billing of $218,176. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Podiatrist
- Location Lyndhurst, NJ
- Active Since 04/09/2007
- Last Updated 11/16/2012
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1740303023
Products in Payments
- HUMULIN (Drug) $121.56
- TRULICITY (Drug) $54.43
- DIVIGEL (Drug) $38.23
- ORTHOVISC (Device) $35.80
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $28.87
- BAQSIMI (Drug) $24.91
- MINIMED 780G (Device) $24.14
- STEGLATRO (Drug) $17.62
- CONTRAVE (Drug) $15.44
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $14.69
- NATPARA (Drug) $14.61
- Evzio (Drug) $14.08
- TRELEGY ELLIPTA (Drug) $14.06
- JARDIANCE (Drug) $13.76
- Prolia (Biological) $13.70
- AFREZZA (Drug) $12.27
- CUBICIN RF (Drug) $12.15
- NATPARA (PARATHYROID HORMONE) (Drug) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.